The Minimum Data Set for Rare Diseases: Systematic Review
Authors:
- Filipe Andrade BernardiFBFilipe Andrade Bernardi
- Bibiana Mello de OliveiraBOBibiana Mello de Oliveira
- Diego Bettiol YamadaDYDiego Bettiol Yamada
- Milena ArtifonMAMilena Artifon
- Amanda Maria SchmidtASAmanda Maria Schmidt
- Victória Machado ScheibeVSVictória Machado Scheibe
- Domingos AlvesDADomingos Alves
- Têmis Maria FélixTFTêmis Maria Félix
Open Access
- 27 July 2023
- journal article
- review article
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25, e44641
Abstract
Background: The minimum data set (MDS) is a collection of data elements to be grouped using a standard approach to allow the use of data for clinical and research purposes. Health data are typically voluminous, complex, and sometimes too ambiguous to generate indicators that can provide knowledge and information on health. This complexity extends further to the rare disease (RD) domain. MDSs are essential for health surveillance as they help provide services and generate recommended population indicators. There is a bottleneck in international literature that reveals a global problem with data collection, recording, and structuring in RD. Objective: This study aimed to identify and analyze the MDSs used for RD in health care networks worldwide and compare them with World Health Organization (WHO) guidelines. Methods: The population, concept, and context methodology proposed by the Joanna Briggs Institute was used to define the research question of this systematic review. A total of 4 databases were reviewed, and all the processes were reported using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. The data elements were analyzed, extracted, and organized into 10 categories according to WHO digital health guidelines. The quality assessment used the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist. Results: We included 20 studies in our review, 70% (n=14) of which focused on a specific health domain and 30% (n=6) of which referred to RD in general. WHO recommends that health systems and networks use standard terminology to exchange data, information, knowledge, and intelligence in health. However, there was a lack of terminological standardization of the concepts in MDSs. Moreover, the selected studies did not follow the same standard structure for classifying the data from their MDSs. All studies presented MDSs with limitations or restrictions because they covered only a specific RD, or their scope of application was restricted to a specific context or geographic region. Data science methods and clinical experience were used to design, structure, and recommend a fundamental global MDS for RD patient records in health care networks. Conclusions: Our study highlights the difficulties in standardizing and categorizing findings from MDSs for RD because of the varying structures used in different studies. The fundamental RD MDS designed in this study comprehensively covers the data needs in the clinical and management sectors. These results can help public policy makers support other aspects of their policies. We highlight the potential of our results to help strategic decisions related to RD. Trial Registration: PROSPERO CRD42021221593; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=221593 International Registered Report Identifier (IRRID): RR2-10.1016/j.procs.2021.12.034Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Minimum Data Set for Cystic Fibrosis Registry: a Case Study in IranActa Informatica Medica, 2015
- National Registries of Rare Diseases in Europe: An Overview of the Current Situation and ExperiencesPublic Health Genomics, 2014
- Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform researchPediatric Rheumatology, 2014
- A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and researchJournal of the American Medical Informatics Association, 2014
- Record linkage between hospital discharges and mortality registries for motor neuron disease case ascertainment for the Spanish National Rare Diseases RegistryAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2014
- Representation of rare diseases in health information systems: The orphanet approach to serve a wide range of end usersHuman Mutation, 2012
- Data management in clinical research: An overviewIndian Journal of Pharmacology, 2012
- Observing Huntington's disease: the European Huntington's Disease Network's REGISTRYJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Editorial: Standards of Reporting: The CONSORT, QUORUM, and STROBE GuidelinesClinical Orthopaedics and Related Research, 2009
- The MPS I registry: Design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type IMolecular Genetics and Metabolism, 2007